Drug Profile
Research programme: silica-based therapeutics - FORMAC Pharmaceuticals/W.R.-Grace
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator FORMAC Pharmaceuticals
- Developer FORMAC Pharmaceuticals; W.R. Grace
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Undefined in Belgium (PO, Capsule)
- 15 Apr 2011 Preclinical trials in an unspecified indication in Belgium (PO)